28073-51-0 Usage
Description
4-(Acetamidomethyl)benzenesulfonylchloride, also known as sacrofen or saclofen, is a chemical compound with the molecular formula C10H12ClNO3S. It is a sulfonyl chloride derivative of benzenesulfonamide and features a sulfonyl chloride functional group attached to a benzene ring. 4-(Acetamidomethyl)benzenesulfonylchloride is an important reagent in organic synthesis and serves as a synthetic intermediate in the production of pharmaceuticals and agrochemicals.
Uses
Used in Pharmaceutical Industry:
4-(Acetamidomethyl)benzenesulfonylchloride is used as a synthetic intermediate for the production of various pharmaceutical compounds. It plays a crucial role in the synthesis of drugs, contributing to the development of new medications and therapies.
Used in Agrochemical Industry:
In the agrochemical sector, 4-(Acetamidomethyl)benzenesulfonylchloride is utilized as a synthetic intermediate in the creation of agrochemicals. It aids in the development of products designed to enhance crop protection and improve agricultural yields.
Used in Organic Synthesis:
4-(Acetamidomethyl)benzenesulfonylchloride is employed as a reagent in organic synthesis, where it is involved in the preparation of a range of research chemicals. Its versatility in chemical reactions makes it valuable for scientific investigations and the advancement of chemical knowledge.
Check Digit Verification of cas no
The CAS Registry Mumber 28073-51-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,8,0,7 and 3 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 28073-51:
(7*2)+(6*8)+(5*0)+(4*7)+(3*3)+(2*5)+(1*1)=110
110 % 10 = 0
So 28073-51-0 is a valid CAS Registry Number.
InChI:InChI=1/C9H10ClNO3S/c1-7(12)11-6-8-2-4-9(5-3-8)15(10,13)14/h2-5H,6H2,1H3,(H,11,12)
28073-51-0Relevant articles and documents
N - aryl sulfonamide compound, its pharmaceutical composition and its use (by machine translation)
-
Paragraph 0199; 0201; 0232-0234, (2019/04/30)
The invention discloses a category represented by the following general formula I N - aryl sulfonamide compound, to the compound as the active ingredient of the pharmaceutical composition, and their preparation for treating Lp - PLA2 In the diseases related to the activity of the use. (by machine translation)